Case-based Conference: Submitting an interesting case report

12 May 2025

Our case report submissions are currently open. If you're thinking of submitting a case report but you could do with some guidance, we have put together some handy prompts below which we hope will help. 

Crystal Arthropathies:

• Do you have a case which highlights the challenge of managing Gout? 
• Do you have a case which has been challenging in managing refractory gout due to multiple drug failures  
• Have you had a case of gout complicated by other co morbidities including CKD. infection? 
• Have you had any gout cases which have involved management from a multidisciplinary team? 
• Do you have any cases of gout treated with biologics or unlicensed drugs e.g., uricosurics successfully?

Inflammatory Myopathies:

• Do you have a case that highlights the diagnostic challenge of distinguishing inflammatory myopathy from other neuromuscular or systemic conditions? 
• Have you had a patient with inflammatory myopathy who has been particularly difficult to manage due to multiple immunosuppressive or biologic therapy failures? 
• Do you have experience managing inflammatory myopathy cases associated with overlap syndromes (e.g. mixed connective tissue disease, systemic sclerosis), and what made them complex? 
• Have you managed a case of statin-induced necrotizing myopathy or drug-related myopathy that presented similarly to idiopathic inflammatory myopathy? 
• Do you have a case involving juvenile dermatomyositis or an atypical age presentation of inflammatory myopathy that posed unique diagnostic or treatment challenges? 
• Do you have an example where multidisciplinary care (e.g. rheumatology, neurology, pulmonology, dermatology, physiotherapy) was pivotal in the management of inflammatory myopathy? 
• Have you treated a case of inflammatory myopathy complicated by interstitial lung disease or other systemic organ involvement, and how did that impact your treatment plan? 
• Do you have cases where monitoring disease activity or response to therapy has been particularly challenging (e.g. due to unreliable CK levels, imaging findings, or autoantibody profiles)? 
• Have you encountered patients with inflammatory myopathy who presented with atypical or refractory skin manifestations (e.g. in dermatomyositis), and how did you address them? 

Axial Spondyloarthropathies:

• Do you have a case which highlights the challenges of managing axial spondyloarthropathies (including ankylosing spondylitis, non-radiographic spondyloarthropathy, psoriatic spondylitis, other inflammatory spinal conditions)? 
• Do have a case which has been challenging in managing due to multiple drug failures? 
• Do you have any cases with associated comorbid conditions with axial spondyloarthropathies? 
• Do you have any interesting abnormal/unusual imaging patterns with your axial spondyloarthropathy cases? 
• Do you have any cases of axial spondyloarthropathy that has required a tailored treatment regime/multiple drug therapies including biologics? 
• Do have any interesting biologic treated axial spondyloarthropathy cases that have proved to be particularly challenging? 
• Do have any patients who have developed other organ complications associated with the axial spondyloarthropathy? 
• Do have any cases of axial spondyloarthropathy that have been difficult to diagnose? 
• Do you have any interesting axial spondyloarthropathy cases which has been difficult to monitor disease activity accurately and what steps were taken to work around this? 
• Do you have any interesting/challenging cases of enthesitis/spondylitis related juvenile arthritis? 
• Do have any cases where a particular multidisciplinary strategy has been required to manage their axial spondyloarthropathy? 
• Do have any examples of non-pharmacological management which has been successful in axial spondyloarthropathy cases? 

Rheumatology Respiratory Disorders:

• Have you had a patient with rheumatoid and progressive lung fibrosis? What were your therapeutic options?
• Have you had any case of patients with RA-ILD or CTD-ILD on immunosuppression who had Pneumocystis?
• Do you have a case of a patient with pulmonary arterial hypertension in the context of systemic sclerosis (or other CTD)? Or perhaps you have a case of a patient in whom you suspected PAH but they transpired to have pulmonary hypertension of a different cause?
• Have you a case where bronchiectasis – or complex lung infections, in the context of immunosuppression – has been the main challenge.
• Have you diagnosed shrinking lung in lupus? How did you treat them and what was the response?
• Have you struggled to treat recurrent pleurisy? What was the underlying diagnosis and what therapeutic strategies did you try

SLE:

• Cases with system specific complications such as renal, neuro or haematological to demonstrate wide range of effects
  general cases

Thieves market:

• interesting cases which demonstrate clear shared learning.

Case report submission will close on Sunday 13 July. Submissions will be reviewed by a panel and your submission may be chosen to be an oral presentation, poster showcase presentation or a poster.